Peripheral Blood Lymphocyte-to-Monocyte Ratio as a Useful Prognostic Factor in Newly Diagnosed Multiple Myeloma
Open Access
- 26 November 2018
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2018, 1-8
Abstract
The survival of individuals with tumors may be predicted by the peripheral blood lymphocyte-to-monocyte ratio (LMR) upon diagnosis in recent studies. For patients with multiple myeloma (MM) in the era of novel agents, the prognostic significance of LMR remains unclear. In this study, the prognostic impact of LMR is evaluated by 285 patients with MM who are treated with proteasome inhibitor and/or immunomodulatory drug. LMR is a proven predictor of survival using the receiver operating characteristic curve, with 4.2 as the cutoff point. Patients with LMR ≤ 4.2 at diagnosis had poorer overall survival (OS) and progression-free survival (PFS) than those with LMR > 4.2. In addition, multivariate analysis showed that LMR less than 4.2 is an independent predictor for the OS (hazard ratio [HR]: 1.703; 95% confidence interval [CI]: 1.020–2.842;P= 0.042) and PFS (HR: 1.831; 95% CI: 1.098–3.053;P= 0.021). According to the test, the LMR at diagnosis, which functions as a simple index reflecting host systemic immunity, can predict clinical outcomes in patients with MM who are treated with new agents.Keywords
Funding Information
- Natural Science Foundation of Beijing Municipality (7162068)
This publication has 36 references indexed in Scilit:
- Prognostic significance of peripheral monocyte count in patients with extranodal natural killer/T-cell lymphomaBMC Cancer, 2013
- Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphomaHaematologica, 2011
- Thalidomide versus bortezomib based regimens as first‐line therapy for patients with multiple myeloma: A systematic reviewAmerican Journal of Hematology, 2010
- Tumor-Associated Macrophages and Survival in Classic Hodgkin's LymphomaNew England Journal of Medicine, 2010
- Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B‐cell lymphomaAmerican Journal of Hematology, 2008
- Bone marrow microenvironment and the identification of new targets for myeloma therapyLeukemia, 2008
- Early lymphocyte recovery predicts longer survival after autologous peripheral blood stem cell transplantation in multiple myelomaBone Marrow Transplantation, 2006
- International Staging System for Multiple MyelomaJournal of Clinical Oncology, 2005
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004
- Inflammation and cancerNature, 2002